Shoulder Function After Cardioverter-Defibrillator Implantation: 5-Year Follow-up.


Journal

The Annals of thoracic surgery
ISSN: 1552-6259
Titre abrégé: Ann Thorac Surg
Pays: Netherlands
ID NLM: 15030100R

Informations de publication

Date de publication:
08 2020
Historique:
received: 01 05 2019
revised: 24 09 2019
accepted: 11 10 2019
pubmed: 22 12 2019
medline: 2 9 2020
entrez: 22 12 2019
Statut: ppublish

Résumé

Implantable cardioverter-defibrillator (ICD) represents the main tool for prevention of sudden cardiac death. Different kinds of postimplant complications have been described; however, little is known about shoulder functional impairment and its impact on quality of life. Patients with standard indications for elective prepectoral subcutaneous ICD insertion were enrolled during a 1-year period. The impact of ICD implantation on shoulder motility, pain, general disability, and quality of life was evaluated prospectively at baseline, and after 2 weeks, 3 months, 1 year, and 5 years using the Constant score, the Numeric Pain Rating Scale, the Disabilities of the Arm, Shoulder, and Hand scale, and the Short Form-36 Health Survey questionnaire. A total of 50 patients underwent insertion of single, dual chamber, or biventricular ICDs. Two weeks after implantation, functional impairment and mild pain were observed in ipsilateral shoulder movements, with a reduction in the Short Form-36 Health Survey score. Shoulder functional impairment improved at the third-month evaluations, with almost normalization at 1-year and 5-year assessments, as well as pain and quality of life. Prepectoral subcutaneous ICD implantation may be associated with ipsilateral shoulder functional impairment that regresses partially after 3 months and completely at 1-year and 5-year assessments. The less invasive implantation technique and the relatively small size of modern ICDs, independently from types and volumes, may be relevant to the degree of postimplantation shoulder functional impairment and recovery time. Shoulder function should be assessed at routine checks, especially soon after ICD implantation because of potential functional impairment and subsequent impact on quality of life.

Sections du résumé

BACKGROUND
Implantable cardioverter-defibrillator (ICD) represents the main tool for prevention of sudden cardiac death. Different kinds of postimplant complications have been described; however, little is known about shoulder functional impairment and its impact on quality of life.
METHODS
Patients with standard indications for elective prepectoral subcutaneous ICD insertion were enrolled during a 1-year period. The impact of ICD implantation on shoulder motility, pain, general disability, and quality of life was evaluated prospectively at baseline, and after 2 weeks, 3 months, 1 year, and 5 years using the Constant score, the Numeric Pain Rating Scale, the Disabilities of the Arm, Shoulder, and Hand scale, and the Short Form-36 Health Survey questionnaire.
RESULTS
A total of 50 patients underwent insertion of single, dual chamber, or biventricular ICDs. Two weeks after implantation, functional impairment and mild pain were observed in ipsilateral shoulder movements, with a reduction in the Short Form-36 Health Survey score. Shoulder functional impairment improved at the third-month evaluations, with almost normalization at 1-year and 5-year assessments, as well as pain and quality of life.
CONCLUSIONS
Prepectoral subcutaneous ICD implantation may be associated with ipsilateral shoulder functional impairment that regresses partially after 3 months and completely at 1-year and 5-year assessments. The less invasive implantation technique and the relatively small size of modern ICDs, independently from types and volumes, may be relevant to the degree of postimplantation shoulder functional impairment and recovery time. Shoulder function should be assessed at routine checks, especially soon after ICD implantation because of potential functional impairment and subsequent impact on quality of life.

Identifiants

pubmed: 31862496
pii: S0003-4975(19)31877-6
doi: 10.1016/j.athoracsur.2019.10.063
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

608-614

Informations de copyright

Copyright © 2020 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Auteurs

Cristian Martignani (C)

Institute of Cardiology, Department of Experimental, Diagnostic, and Speciality Medicine, Policlinico S. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy. Electronic address: cristian.martignani@gmail.com.

Giulia Massaro (G)

Institute of Cardiology, Department of Experimental, Diagnostic, and Speciality Medicine, Policlinico S. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.

Andrea Mazzotti (A)

Institute of Cardiology, Department of Experimental, Diagnostic, and Speciality Medicine, Policlinico S. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.

Francesco Pegreffi (F)

Institute of Sport Medicine, University of Bologna, Bologna, Italy.

Matteo Ziacchi (M)

Institute of Cardiology, Department of Experimental, Diagnostic, and Speciality Medicine, Policlinico S. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.

Mauro Biffi (M)

Institute of Cardiology, Department of Experimental, Diagnostic, and Speciality Medicine, Policlinico S. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.

Giuseppe Porcellini (G)

Unit of Shoulder and Elbow Surgery, D. Cervesi Hospital, Cattolica University, Cattolica, Italy.

Giuseppe Boriani (G)

Cardiovascular Division, Modena University Hospital, University of Modena and Reggio Emilia, Modena, Italy.

Igor Diemberger (I)

Institute of Cardiology, Department of Experimental, Diagnostic, and Speciality Medicine, Policlinico S. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH